Table 1.
Case group1 (28 eyes) | Case group2 (30 eyes) | Control group (29 eyes) | F | P | P1-2 | P1-3 | P2-3 | |
---|---|---|---|---|---|---|---|---|
BCVA (LogMAR) | 0.407 ± 0.295 | 0.103 ± 0.118 | 0.117 ± 0.110 | 12.657 | 0.000* | 0.000* | 0.000* | 0.782 |
MD (dB) | − 2.157 ± 1.940 | − 1.953 ± 2.091 | − 0.169 ± 0.071 | 12.694 | 0.000* | 0.639 | 0.000* | 0.000* |
Age | 62.857 ± 10.848 | 59.300 ± 6.114 | 59.069 ± 6.823 | 1.937 | 0.151 | 0.100 | 0.083 | 0.913 |
IOP (mmHg) | 22.964 ± 7.366 | 16.700 ± 2.306 | 15.241 ± 2.487 | 22.418 | 0.000* | 0.000* | 0.000* | 0.229 |
Case group 1 represents early CPACG patients. Case group 2 represents newly diagnosed PA patients.